High-dose dazucorilant showed significant survival benefit in a Phase 2 ALS trial. It reduced mortality risk by up to 87% over two years for ALS patients. A pivotal Phase 3 trial for this ALS therapy ...
A recent study discovered measurable poison in wild false morel mushrooms eaten before a rare cluster of the fatal nerve ...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes the progressive loss of motor neurons, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results